Effect of Extracorporeal Shock Wave Therapy of Gastrosoleus Trigger Points in Patients With Plantar Fasciitis

The Effect of Extracorporeal Shock Wave Therapy (ESWT)of Gastrosoleus Trigger Points in Patients With Plantar Fasciitis

Status

UNKNOWN

Phases

Phase 2Phase 3

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01786057

Enrollment

Registered

2013-02-07

Start date

2012-11-30

Completion date

2013-10-31

Last updated

2013-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Plantar Fasciitis

Brief summary

Plantar fasciitis is one of the most common causes of heel pain. This study will be performed in the purpose of determination the effects of extracorporeal shock wave therapy of gastrosoleus trigger points in patients with plantar fasciitis

Detailed description

Plantar fasciitis is the most common cause of inferior heel pain, A great variety of therapies have been reported for the treatment of plantar fasciitis including extracorporeal shock wave therapy. Gastrosoleus muscle dysfunction is one of the most common contributing factors to this disease .Despite the long history and the fact that this is a common diagnosis made in clinical practice, the exact cause and best treatment for this condition still are being explored. Although there is lack of high-quality studies demonstrating the efficacy of extracorporeal shock wave therapy of gastrosoleus trigger points in patients with plantar fasciitis , this study will be performed to examine the effect of extracorporeal shock wave therapy of gastrosoleus trigger points in patients with plantar fasciitis

Interventions

PROCEDUREExtracorporeal shock wave therapy 1

Extracorporeal shock wave therapy , (3000 shock waves/session of 0.2 mJ/mm2) for heel region and (400 shock waves/session of 0.2 mJ/mm2 per each trigger point) for gastrosoleus trigger points , 3 sessions at weekly intervals

PROCEDUREExtracorporeal shock wave therapy 2

Extracorporeal shock wave therapy , (3000 shock waves/session of 0.2 mJ/mm2) for heel region , 3 sessions at weekly intervals

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

20 Years to No maximum

Healthy volunteers

Inclusion criteria

1. clinical diagnosis of plantar fasciitis 2. having at least one Gastrosoleus trigger point concomitantly. 3. having no response to conservative treatments for at least 3 months 4. willingness to participate

Exclusion criteria

1. Dysfunction of the knee or ankle 2. Neurologic abnormalities 3. Bleeding tendency (hereditary or acquired) 4. Nerve entrapment syndrome 5. A previous operation on the heel 6. Pregnancy 7. Evidences of Infection in lower limbs 8. A medical History of tumor 9. previous local corticosteroid injection within 12 weeks

Design outcomes

Primary

Measure	Time frame	Description
Change from baseline in pain severity after 3 weeks	Up to 4 weeks	The pain score (100 mm Visual Analogue Score ) is evaluated before the first session and 4 weeks after the last session.

Secondary

Measure	Time frame	Description
Change from baseline in pain degree after 2 months.	Up to 2 months	The pain score (100 mm Visual Analogue Score ) and the modified criteria of the Roles and Maudsley score are evaluated at baseline and then 2 months after therapy.

Countries

Iran

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026